Higher insulin does not raise death risk in diabetes

07/1/2013 | Healio

Higher insulin doses were not associated with the increased risk of all-cause and cardiovascular mortality seen in diabetes patients receiving intensive treatment, a study presented at the ADA 73rd Scientific Sessions showed. Higher A1C was linked to a higher risk of cardiovascular death before and after adjustment for insulin exposure, researchers said.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX